港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

生物医药B类股

430.463

+8.7162.07%

涨家数：27

跌家数：4

平家数：3

市盈率：- -

高：431.911

开：421.747

低：421.747

收：421.747

数据加载中...

总览新闻资讯

沛嘉医疗－Ｂ(09996)股价显著上升12.23%，现价港币$4.68

阿斯达克财经

同源康医药-B盘中异动下午盘股价大跌6.45%报29.000港元

欧康维视生物-B盘中异动股价大涨5.15%报4.900港元

创新药概念震荡拉升热景生物涨超15%创2年多新高

南方财经网

【欧普康视等成立眼视光科技公司含诊所服务业务】公开资料显示，近日，郑州欧普康视眼视光科技有限公司成立，法定代表人为闫霞，注册资本100万元，经营范围包含：第一类医疗器械销售；诊所服务；电子产品销售；文具用品零售；体育用品及器材零售；医院管理；企业管理；品牌管理等。股权数据显示，该公司由河南一眸科技有限公司、欧普康视旗下欧普康视投资有限公司共同持股。

心通医疗-B(02160)上涨20.79%，报1.22元/股

华领医药－Ｂ(02552)股价下跌5.328%，现价港币$2.31

阿斯达克财经

医药外包概念股集体走强维亚生物涨6.77% 机构指AI技术渗透加速CXO产业范式革新

荣昌生物盘中异动下午盘急速拉升5.19%

稀缺科创生物医药新股！全球竞争优势明显，利润3年翻了近四倍

科济药业-B盘中异动下午盘急速上涨5.00%报15.960港元

华东医药：公司与科济药业合作进行商业化的赛恺泽产品目前市场拓展顺利

和铂医药-B盘中异动股价大涨5.02%报6.280港元

徐冠巨代表：及时修订《国民经济行业分类》，纳入新兴产业

和铂医药-B盘中涨超4% 收到Windward Bio授权协议首付款

港股异动 | 德琪医药-B(06996)涨超14% 公司计划加大AI药物研发投入希维奥®在印度尼西亚获批上市

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK1574/news?page=3"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物医药B类股","latestPrice":430.4633,"timestamp":1741248510375,"preClose":421.74713,"halted":0,"volume":196751826,"delay":0,"changeRate":0.020667,"change":8.716156,"pbRate":3.352817,"amount":2078205803,"amplitude":0.024099,"prevYearClose":331.1933,"fiveDayClose":431.446,"twentyDayClose":333.662,"turnoverRate":0.00762,"marketCap":241153069920,"floatMarketCap":226975358368,"peRate":-16.712341},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":431.91098,"amplitude":0.024099,"preClose":421.74713,"low":421.74713,"pbRate":"3.352817","latestPrice":430.4633,"volume":196751826,"delay":0,"open":421.74713,"prevYearClose":331.1933,"prevWeekClose":411.011,"prevMonthClose":411.011,"prevQuarterClose":331.193,"fiveDayClose":431.446,"twentyDayClose":333.662,"sixtyDayClose":346.493,"secType":"PLATE","market":"HK","turnoverRate":0.00762,"peRate":-16.712341,"marketCap":241153069920,"floatMarketCap":226975358368,"timestamp":1741248510375,"nameCN":"生物医药B类股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":27,"down":4,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:16,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517868251","title":"沛嘉医疗－Ｂ(09996)股价显著上升12.23%，现价港币$4.68","url":"https://stock-news.laohu8.com/highlight/detail?id=2517868251","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517868251?lang=zh_cn&edition=fundamental","pubTime":"2025-03-06 14:40","pubTimestamp":1741243200,"startTime":"0","endTime":"0","summary":"[上升股]沛嘉医疗－Ｂ(09996) 股价在下午02:40比前收市价显著上升12.23%，现股价为港币$4.68。至目前为止，今日最高价为$4.68，而最低价为$4.21。总成交量为347.3万股，总成交金额为港币$1.573千万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126133719348_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126133719348_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2503068824/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","159891","BK1100","09996","BK1583"],"gpt_icon":0},{"id":"2517186478","title":"同源康医药-B盘中异动 下午盘股价大跌6.45%报29.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517186478","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517186478?lang=zh_cn&edition=fundamental","pubTime":"2025-03-06 14:23","pubTimestamp":1741242194,"startTime":"0","endTime":"0","summary":"2025年03月06日下午盘14时23分，同源康医药-B股票出现波动，股价急速跳水6.45%。截至发稿，该股报29.000港元/股，成交量39.85万股，换手率0.11%，振幅9.52%。资金方面，该股资金流入665.168万港元，流出549.195万港元。同源康医药-B股票所在的生物技术行业中，整体涨幅为0.51%。同源康医药-B公司简介：浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306142314abeada0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306142314abeada0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","BK1515","BK1161","BK1574","09939"],"gpt_icon":0},{"id":"2517183534","title":"欧康维视生物-B盘中异动 股价大涨5.15%报4.900港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517183534","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517183534?lang=zh_cn&edition=fundamental","pubTime":"2025-03-06 14:13","pubTimestamp":1741241592,"startTime":"0","endTime":"0","summary":"2025年03月06日下午盘14时13分，欧康维视生物-B股票出现波动，股价快速上涨5.15%。截至发稿，该股报4.900港元/股，成交量183.45万股，换手率0.22%，振幅5.15%。资金方面，该股资金流入534.561万港元，流出211.619万港元。欧康维视生物-B股票所在的生物技术行业中，整体涨幅为0.48%。欧康维视生物-B公司简介：欧康维视生物是一家主要从事眼科疗法发现、开发及商业化业务的中国控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306141312a261ef0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306141312a261ef0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01477","BK1191","BK1574"],"gpt_icon":0},{"id":"2517883931","title":"创新药概念震荡拉升 热景生物涨超15%创2年多新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2517883931","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517883931?lang=zh_cn&edition=fundamental","pubTime":"2025-03-06 13:56","pubTimestamp":1741240575,"startTime":"0","endTime":"0","summary":"南方财经3月6日电，创新药概念震荡拉升，午后热景生物拉升涨超15%，股价创2年多新高，博瑞医药涨近10%，诺思格、一品红、荣昌生物、艾力斯、药明康德等涨幅靠前。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503063338418745.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","BK1574","06978"],"gpt_icon":0},{"id":"2517334188","title":"【欧普康视等成立眼视光科技公司 含诊所服务业务】 公开资料显示，近日，郑州欧普康视眼视光科技有限公司成立，法定代表人为闫霞，注册资本100万元，经营范围包含：第一类医疗器械销售；诊所服务；电子产品销售；文具用品零售；体育用品及器材零售；医院管理；企业管理；品牌管理等。股权数据显示，该公司由河南一眸科技有限公司、欧普康视旗下欧普康视投资有限公司共同持股。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517334188","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517334188?lang=zh_cn&edition=fundamental","pubTime":"2025-03-06 13:55","pubTimestamp":1741240523,"startTime":"0","endTime":"0","summary":"公开资料显示，近日，郑州欧普康视眼视光科技有限公司成立，法定代表人为闫霞，注册资本100万元，经营范围包含：第一类医疗器械销售；诊所服务；电子产品销售；文具用品零售；体育用品及器材零售；医院管理；企业管理；品牌管理等。股权数据显示，该公司由河南一眸科技有限公司、欧普康视旗下欧普康视投资有限公司共同持股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/06135548557348.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["09996","BK1583","BK0251","159883","09997","BK1222","300595","BK1574","BK1100"],"gpt_icon":0},{"id":"2517188327","title":"心通医疗-B(02160)上涨20.79%，报1.22元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2517188327","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517188327?lang=zh_cn&edition=fundamental","pubTime":"2025-03-06 13:51","pubTimestamp":1741240306,"startTime":"0","endTime":"0","summary":"3月6日，心通医疗-B盘中上涨20.79%，截至13:51，报1.22元/股，成交2516.96万元。心通医疗是一家中国领先的医疗器械企业，主要从事结构性心脏病领域的经导管和手术解决方案的研发和商业化，产品包括VitaFlow系列经导管主动脉瓣植入产品、经导管二尖瓣治疗产品、经导管三尖瓣治疗产品、外科瓣膜产品和手术配件等。截至2024年中报，心通医疗-B营业总收入2.23亿元、净利润-5646.1万元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/03/06135148557357.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1574","02160","BK1583","BK1100"],"gpt_icon":0},{"id":"2517188442","title":"华领医药－Ｂ(02552)股价下跌5.328%，现价港币$2.31","url":"https://stock-news.laohu8.com/highlight/detail?id=2517188442","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517188442?lang=zh_cn&edition=fundamental","pubTime":"2025-03-06 13:50","pubTimestamp":1741240200,"startTime":"0","endTime":"0","summary":"[下跌股]华领医药－Ｂ(02552) 股价在下午01:50比前收市价下跌5.328%，现股价为港币$2.31。至目前为止，今日最高价为$2.59，而最低价为$2.31。总成交量为756.05万股，总成交金额为港币$1.857千万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150425748_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150425748_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2503062736/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","BK1191","02552"],"gpt_icon":0},{"id":"2517512188","title":"医药外包概念股集体走强 维亚生物涨6.77% 机构指AI技术渗透加速CXO产业范式革新","url":"https://stock-news.laohu8.com/highlight/detail?id=2517512188","media":"金吾资讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517512188?lang=zh_cn&edition=fundamental","pubTime":"2025-03-06 13:48","pubTimestamp":1741240123,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药外包概念股集体走强，截至发稿，维亚生物 涨6.77%，康龙化成涨3.92%，泰格医药和药明康德涨3.24%，药明生物涨2.38%消息面上，国泰君安发布研报称，AI技术渗透加速CXO产业范式革新。AI技术在生物医药领域深度应用有望重构CXO产业价值链。全球药企降本增效诉求升级，叠加AI技术成熟度提升，驱动CXO企业加速智能化转型。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306134913963bb5f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306134913963bb5f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1515","BK1161","03347","09939","BK1574","02359","01873","BK1141","03759"],"gpt_icon":0},{"id":"2517890030","title":"荣昌生物盘中异动 下午盘急速拉升5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517890030","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517890030?lang=zh_cn&edition=fundamental","pubTime":"2025-03-06 13:34","pubTimestamp":1741239266,"startTime":"0","endTime":"0","summary":"2025年03月06日下午盘13时34分，荣昌生物股票出现波动，股价急速上涨5.19%。截至发稿，该股报17.840港元/股，成交量271.55万股，换手率1.43%，振幅4.95%。荣昌生物股票所在的生物技术行业中，整体涨幅为0.51%。荣昌生物公司简介：研发、生产和销售医药产品、诊断试剂产品,以及进行与上述产品及其研发相关的技术服务、技术转让,货物或技术进出口。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306133426989e1cd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306133426989e1cd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09995","BK1583","LU1969619763.USD","BK1574","LU2328871848.SGD","BK1161"],"gpt_icon":0},{"id":"2517092188","title":"稀缺科创生物医药新股！全球竞争优势明显，利润3年翻了近四倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2517092188","media":"海豚音","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517092188?lang=zh_cn&edition=fundamental","pubTime":"2025-03-06 13:21","pubTimestamp":1741238460,"startTime":"0","endTime":"0","summary":"能否成为下一个生物医药趋势牛股，且看海豚今日为你深度剖析！微球第一股纳微科技采用耗材+仪器双轮驱动，除了色谱介质外还涉足分析色谱仪、平板显示用微球、体外诊断用微球等领域，相比之下赛分科技则主要聚焦于药物及生物大分子分离纯化液相色谱材料领域。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-03-06/doc-inenswii7959986.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1515","BK1161","BK1574","09939","159938","000683.SH"],"gpt_icon":0},{"id":"2517318854","title":"科济药业-B盘中异动 下午盘急速上涨5.00%报15.960港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517318854","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517318854?lang=zh_cn&edition=fundamental","pubTime":"2025-03-06 13:11","pubTimestamp":1741237872,"startTime":"0","endTime":"0","summary":"2025年03月06日下午盘13时11分，科济药业-B股票出现异动，股价快速拉升5.00%。截至发稿，该股报15.960港元/股，成交量434.15万股，换手率0.76%，振幅5.00%。科济药业-B股票所在的生物技术行业中，整体涨幅为0.35%。2月26日，科济药业公告披露，旗下优恺泽生物完成珠海软银主导的8000万元战略融资，对应估值达10亿元。科济药业的转型之路颇具行业启示意义。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306131112963baef8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306131112963baef8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1585","BK1574","BK1161","BK1587","02171"],"gpt_icon":0},{"id":"2517188360","title":"华东医药：公司与科济药业合作进行商业化的赛恺泽 产品目前市场拓展顺利","url":"https://stock-news.laohu8.com/highlight/detail?id=2517188360","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517188360?lang=zh_cn&edition=fundamental","pubTime":"2025-03-06 13:04","pubTimestamp":1741237440,"startTime":"0","endTime":"0","summary":"登录新浪财经APP 搜索【信披】查看更多考评等级\n　　证券之星消息，华东医药(000963)03月05日在投资者关系平台上答复投资者关心的问题。　　投资者：贵公司今后还有没有和科济药业继续合作的项目？　　华东医药董秘：您好！公司与科济药业合作进行商业化的赛恺泽产品目前市场拓展顺利。今后公司如有进一步的对外合作计划，将按照信息披露相关规定及时公告。感谢您的关注！\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-03-06/doc-inenswir0946806.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","BK0132","BK0175","BK1574","BK1587","000963","BK0209","BK0187","BK0188","BK0196","BK0183","BK1585","LU1969619763.USD","02171","LU2328871848.SGD"],"gpt_icon":0},{"id":"2517076419","title":"和铂医药-B盘中异动 股价大涨5.02%报6.280港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517076419","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517076419?lang=zh_cn&edition=fundamental","pubTime":"2025-03-06 13:01","pubTimestamp":1741237292,"startTime":"0","endTime":"0","summary":"2025年03月06日下午盘13时01分，和铂医药-B股票出现波动，股价快速上涨5.02%。截至发稿，该股报6.280港元/股，成交量660.5万股，换手率0.87%，振幅4.68%。资金方面，该股资金流入1951.4万港元，流出1642.73万港元。和铂医药-B股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，迈博药业-B、创胜集团-B、帝王国际投资涨幅较大，振幅较大的相关个股有迈博药业-B、帝王国际投资、创胜集团-B，振幅分别为75.76%、48.28%、24.84%。该公司的产品包括HBM9161, HBM4003, HBM7008 and HBM1020。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306130132a261db10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306130132a261db10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1583","02142","BK1161"],"gpt_icon":0},{"id":"2517904166","title":"徐冠巨代表：及时修订《国民经济行业分类》，纳入新兴产业","url":"https://stock-news.laohu8.com/highlight/detail?id=2517904166","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517904166?lang=zh_cn&edition=fundamental","pubTime":"2025-03-06 12:32","pubTimestamp":1741235521,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["09939","BK0239","BK1161","300832","159938","BK1574","BK1515"],"gpt_icon":0},{"id":"2517093909","title":"和铂医药-B盘中涨超4% 收到Windward Bio授权协议首付款","url":"https://stock-news.laohu8.com/highlight/detail?id=2517093909","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517093909?lang=zh_cn&edition=fundamental","pubTime":"2025-03-06 11:50","pubTimestamp":1741233000,"startTime":"0","endTime":"0","summary":"　　和铂医药-B盘中涨超4%，截至发稿，股价上涨3.34%，现报6.18港元，成交额3817.96万港元。　　和铂医药宣布，根据其与科伦博泰就HBM9378/SKB378与Windward Bio AG签订的许可协议，公司已收到相应首付款，包括现金付款及Windward Bio母公司股权。根据2025年1月10日签订的许可协议，Windward Bio获得HBM9378/SKB378在全球范围内进行研究、开发、生产和商业化的独家授权。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-03-06/doc-inensrzp6938284.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","BK1583","02142","BK1161"],"gpt_icon":0},{"id":"2517990939","title":"港股异动 | 德琪医药-B(06996)涨超14% 公司计划加大AI药物研发投入 希维奥®在印度尼西亚获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2517990939","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517990939?lang=zh_cn&edition=fundamental","pubTime":"2025-03-06 11:33","pubTimestamp":1741231981,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，德琪医药-B涨超14%，该股年内累计涨幅达390%。截至发稿，涨14.18%，报3.22港元，成交额1496.4万港元。消息面上，德琪医药昨日宣布，印度尼西亚食品药品监督管理局已批准希维奥的新药上市申请。值得一提的是，今年2月，德琪医药宣布计划加大投入，整合资源成立专门的AI部门。据悉，公司早在2021年便以天使投资人身份投资杭州德睿智药AI药物发现平台，并借此战略性的切入了AI药物发现赛道。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258407.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06996","BK1583","BK1574","BK1191"],"gpt_icon":0}],"pageSize":16,"totalPage":43,"pageCount":3,"totalSize":675}]}}